Leggett Thomas Insider Trades

Insider Trading History

Track insider trading activity for Leggett Thomas. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Stoke Therapeutics
Stoke Therapeutics STOK
Chief Financial Officer
Holding Value $313k 10,381 shares
Last Trade
Mar 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$74.7k 2,382 shares
$31.34
$30.12
Stoke Therapeutics
Stoke Therapeutics STOK
Chief Financial Officer
Holding Value $406k 13,476 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$72.5k 2,196 shares
$33.01
$30.12
Stoke Therapeutics
Stoke Therapeutics STOK
Chief Financial Officer
Holding Value $1.33M 44,250 shares
Last Trade
Mar 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$490k 14,750 shares
$33.19
$30.12
Stoke Therapeutics
Stoke Therapeutics STOK
Chief Financial Officer
Holding Value $444k 14,750 shares
Last Trade
Mar 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$490k 14,750 shares
$33.19
$30.12
Stoke Therapeutics
Stoke Therapeutics STOK
Chief Financial Officer
Holding Value $1.81M 60,000 shares
Last Trade
Feb 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.11M 100,000 shares
$31.09
$30.12
Stoke Therapeutics
Stoke Therapeutics STOK
Chief Financial Officer
Holding Value $2.68M 89,000 shares
Last Trade
Mar 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$741k 89,000 shares
$8.33
$30.12
Stoke Therapeutics
Stoke Therapeutics STOK
Chief Financial Officer
Holding Value $11.9M 396,200 shares
Last Trade
May 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.6M 396,200 shares
$14.13
$30.12
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Chief Financial Officer
Holding Value $157k 75,000 shares
Last Trade
Feb 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.15M 75,000 shares
$28.69
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Chief Financial Officer
Holding Value $456k 218,171 shares
Last Trade
Jan 08, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102k 3,000 shares
$34.11
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jan 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$102k 3,000 shares
$33.94
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Chief Financial Officer
Holding Value $6.27k 3,000 shares
Last Trade
Jan 08, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102k 3,000 shares
$34.11
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Chief Financial Officer
Holding Value $6.27k 3,000 shares
Last Trade
Dec 08, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102k 3,000 shares
$34.10
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Chief Financial Officer
Holding Value $4.06k 1,941 shares
Last Trade
Dec 08, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$101k 3,000 shares
$33.78
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Chief Financial Officer
Holding Value $462k 221,171 shares
Last Trade
Dec 08, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102k 3,000 shares
$34.10
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Nov 09, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$98.9k 3,000 shares
$32.96
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Chief Financial Officer
Holding Value $469k 224,171 shares
Last Trade
Nov 09, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$96.2k 3,000 shares
$32.06
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Chief Financial Officer
Holding Value $6.27k 3,000 shares
Last Trade
Nov 09, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$96.2k 3,000 shares
$32.06
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Oct 08, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$101k 3,000 shares
$33.53
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Chief Financial Officer
Holding Value $6.27k 3,000 shares
Last Trade
Oct 08, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$99.8k 3,000 shares
$33.27
$2.09
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Chief Financial Officer
Holding Value $475k 227,171 shares
Last Trade
Oct 08, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$99.8k 3,000 shares
$33.27
$2.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up